<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Rosacea Support Group</title>
	<atom:link href="https://rosacea-support.org/feed" rel="self" type="application/rss+xml" />
	<link>https://rosacea-support.org</link>
	<description>Where the rosacea community meets to support each other</description>
	<lastBuildDate>Sat, 24 Jan 2026 01:19:49 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://i0.wp.com/rosacea-support.org/wp-content/uploads/2016/02/cropped-191057037_f0f1008454_b.jpeg?fit=32%2C32&#038;ssl=1</url>
	<title>Rosacea Support Group</title>
	<link>https://rosacea-support.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">2921305</site>	<item>
		<title>Protopic &#8211; is it good for rosacea or not?</title>
		<link>https://rosacea-support.org/protopic-is-it-good-for-rosacea-or-not.html</link>
					<comments>https://rosacea-support.org/protopic-is-it-good-for-rosacea-or-not.html#respond</comments>
		
		<dc:creator><![CDATA[David Pascoe]]></dc:creator>
		<pubDate>Sat, 24 Jan 2026 01:19:49 +0000</pubDate>
				<category><![CDATA[Off Label Treatments]]></category>
		<guid isPermaLink="false">https://rosacea-support.org/?p=14697</guid>

					<description><![CDATA[A 2024 review article by dermatologist D.D. Petrunin (published in a Russian dermatology journal) looks back at over 20 years of experience using tacrolimus ointment (a topical calcineurin inhibitor, often sold as Protopic 0.03% or 0.1%) for skin conditions beyond its official approval (which is mainly for atopic dermatitis/eczema). The paper focuses on off-label uses, [&#8230;]]]></description>
		
					<wfw:commentRss>https://rosacea-support.org/protopic-is-it-good-for-rosacea-or-not.html/feed</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">14697</post-id>	</item>
		<item>
		<title>A breakthrough in Neurogenic Rosacea research</title>
		<link>https://rosacea-support.org/a-breakthrough-in-neurogenic-rosacea-research.html</link>
					<comments>https://rosacea-support.org/a-breakthrough-in-neurogenic-rosacea-research.html#comments</comments>
		
		<dc:creator><![CDATA[David Pascoe]]></dc:creator>
		<pubDate>Sat, 17 Jan 2026 02:27:54 +0000</pubDate>
				<category><![CDATA[Is Rosacea Genetic?]]></category>
		<category><![CDATA[Neurogenic Rosacea]]></category>
		<category><![CDATA[What Causes Rosacea?]]></category>
		<guid isPermaLink="false">https://rosacea-support.org/?p=14306</guid>

					<description><![CDATA[If you live with rosacea, you know how frustrating it can be—persistent facial redness, flushing, burning, stinging, and sometimes even papules or pustules that just won&#8217;t quit. For many of us, standard treatments like antibiotics, metronidazole, or low-dose isotretinoin help manage symptoms. But there&#8217;s a subset of rosacea sufferers who don&#8217;t respond well to these [&#8230;]]]></description>
		
					<wfw:commentRss>https://rosacea-support.org/a-breakthrough-in-neurogenic-rosacea-research.html/feed</wfw:commentRss>
			<slash:comments>7</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">14306</post-id>	</item>
		<item>
		<title>Metrogel no longer available in the US</title>
		<link>https://rosacea-support.org/metrogel-no-longer-available-in-the-us.html</link>
					<comments>https://rosacea-support.org/metrogel-no-longer-available-in-the-us.html#comments</comments>
		
		<dc:creator><![CDATA[David Pascoe]]></dc:creator>
		<pubDate>Tue, 13 Jan 2026 00:28:41 +0000</pubDate>
				<category><![CDATA[Galderma]]></category>
		<category><![CDATA[Metrogel 1%]]></category>
		<guid isPermaLink="false">https://rosacea-support.org/?p=14676</guid>

					<description><![CDATA[Without any announcement Galderma has discontinued manufacturing and selling the branded MetroGel (metronidazole topical gel, typically 1% for rosacea) in the United States. While no official public announcement details the exact timeline, the product no longer appears in Galderma&#8217;s current U.S. portfolio, with the shift occurring gradually as generics entered the market. Why did Galderma [&#8230;]]]></description>
		
					<wfw:commentRss>https://rosacea-support.org/metrogel-no-longer-available-in-the-us.html/feed</wfw:commentRss>
			<slash:comments>2</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">14676</post-id>	</item>
		<item>
		<title>Rosacea redness – the new treatments you haven’t heard of</title>
		<link>https://rosacea-support.org/rosacea-redness-the-new-treatments-you-havent-heard-of.html</link>
					<comments>https://rosacea-support.org/rosacea-redness-the-new-treatments-you-havent-heard-of.html#respond</comments>
		
		<dc:creator><![CDATA[David Pascoe]]></dc:creator>
		<pubDate>Sun, 11 Jan 2026 11:49:31 +0000</pubDate>
				<category><![CDATA[Red Face of Rosacea]]></category>
		<guid isPermaLink="false">https://rosacea-support.org/?p=14663</guid>

					<description><![CDATA[A study published in the Journal of Cutaneous Medicine and Surgery in 2024 has looked into which treatments work best to reduce the much-hated rosacea redness. Let’s break it down in a way that’s easy to understand. What’s Rosacea and Why Redness Matters Rosacea is a common skin condition affecting an incredible 5% of people [&#8230;]]]></description>
		
					<wfw:commentRss>https://rosacea-support.org/rosacea-redness-the-new-treatments-you-havent-heard-of.html/feed</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">14663</post-id>	</item>
		<item>
		<title>Rosacea &#8211; help, where do I start?</title>
		<link>https://rosacea-support.org/rosacea-help-where-do-i-start.html</link>
					<comments>https://rosacea-support.org/rosacea-help-where-do-i-start.html#comments</comments>
		
		<dc:creator><![CDATA[David Pascoe]]></dc:creator>
		<pubDate>Wed, 07 Jan 2026 12:08:12 +0000</pubDate>
				<category><![CDATA[Rosacea Fact Sheets]]></category>
		<guid isPermaLink="false">https://rosacea-support.org/?p=14354</guid>

					<description><![CDATA[Welcome to Rosacea-Support.org: Your Guide to Understanding and Treating Rosacea. If you’re new to Rosacea-Support.org, welcome! You’re joining a vibrant community dedicated to helping those with rosacea navigate this chronic skin condition. Rosacea affects over 16 million Americans and up to 415 million people worldwide, causing facial redness, bumps, visible blood vessels, and sometimes ocular [&#8230;]]]></description>
		
					<wfw:commentRss>https://rosacea-support.org/rosacea-help-where-do-i-start.html/feed</wfw:commentRss>
			<slash:comments>1</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">14354</post-id>	</item>
		<item>
		<title>Welcome to the new look rosacea-support.org</title>
		<link>https://rosacea-support.org/welcome-to-the-new-look-rosacea-support-org.html</link>
					<comments>https://rosacea-support.org/welcome-to-the-new-look-rosacea-support-org.html#respond</comments>
		
		<dc:creator><![CDATA[David Pascoe]]></dc:creator>
		<pubDate>Sat, 03 Jan 2026 07:29:11 +0000</pubDate>
				<category><![CDATA[research]]></category>
		<guid isPermaLink="false">https://rosacea-support.org/?p=14556</guid>

					<description><![CDATA[I hope you have noticed the new look for rosacea-support.org. I have replaced the old no-longer supported template to a new block-based theme as is the way that WordPress sites are heading. The site now has a much cleaner and simpler look, hopefully much faster, easier to read and move around. It was fun to [&#8230;]]]></description>
		
					<wfw:commentRss>https://rosacea-support.org/welcome-to-the-new-look-rosacea-support-org.html/feed</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">14556</post-id>	</item>
		<item>
		<title>Emrosi &#8211; what you need to know</title>
		<link>https://rosacea-support.org/emrosi-what-you-need-to-know.html</link>
					<comments>https://rosacea-support.org/emrosi-what-you-need-to-know.html#comments</comments>
		
		<dc:creator><![CDATA[David Pascoe]]></dc:creator>
		<pubDate>Sat, 30 Aug 2025 13:34:05 +0000</pubDate>
				<category><![CDATA[Emrosi (minocycline 40mg)]]></category>
		<category><![CDATA[Minocycline]]></category>
		<category><![CDATA[Oracea (40mg doxycycline)]]></category>
		<guid isPermaLink="false">https://rosacea-support.org/?p=14350</guid>

					<description><![CDATA[For the past almost 2 decades the only FDA-approved oral medication for rosacea has been Oracea (doxycycline 40 mg). However, this has changed: Emrosi, a minocycline-based oral treatment that promises superior results for managing the inflammatory lesions and redness of rosacea is now available. Approved by the FDA in November 2024, Emrosi may be about [&#8230;]]]></description>
		
					<wfw:commentRss>https://rosacea-support.org/emrosi-what-you-need-to-know.html/feed</wfw:commentRss>
			<slash:comments>1</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">14350</post-id>	</item>
		<item>
		<title>EMROSI (was DFD-29) has been approved for rosacea</title>
		<link>https://rosacea-support.org/emrosi-was-dfd-29-has-been-approved-for-rosacea.html</link>
					<comments>https://rosacea-support.org/emrosi-was-dfd-29-has-been-approved-for-rosacea.html#comments</comments>
		
		<dc:creator><![CDATA[David Pascoe]]></dc:creator>
		<pubDate>Tue, 05 Nov 2024 12:51:45 +0000</pubDate>
				<category><![CDATA[Emrosi (minocycline 40mg)]]></category>
		<category><![CDATA[Minocycline]]></category>
		<category><![CDATA[New Rosacea Treatments]]></category>
		<guid isPermaLink="false">https://rosacea-support.org/?p=14338</guid>

					<description><![CDATA[Journey Medical Corporation has announced that their product formerly known as DFD-29, now known as EMROSI has been approved by the FDA for the treatment of the papules and pustules of rosacea. Each EMROSI extended-release capsule contains 40 mg of minocycline (equivalent to 43.19 mgof minocycline hydrochloride) as 10 mg immediate-release and 30 mg extended-release [&#8230;]]]></description>
		
					<wfw:commentRss>https://rosacea-support.org/emrosi-was-dfd-29-has-been-approved-for-rosacea.html/feed</wfw:commentRss>
			<slash:comments>1</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">14338</post-id>	</item>
		<item>
		<title>Finding new rosacea drugs with computer models `in-silico&#8217;</title>
		<link>https://rosacea-support.org/finding-new-rosacea-drugs-with-computer-models-in-silico.html</link>
					<comments>https://rosacea-support.org/finding-new-rosacea-drugs-with-computer-models-in-silico.html#respond</comments>
		
		<dc:creator><![CDATA[David Pascoe]]></dc:creator>
		<pubDate>Tue, 09 Jul 2024 01:39:01 +0000</pubDate>
				<category><![CDATA[research]]></category>
		<category><![CDATA[What Causes Rosacea?]]></category>
		<guid isPermaLink="false">https://rosacea-support.org/?p=14329</guid>

					<description><![CDATA[I&#8217;m tempted to include AI somehow in this article title &#8211; because, you know, AI is the new answer to all our old problems, right? This really intriguing article actually has nothing to do with Artificial Intelligence, much more to do with the intelligence by applying clever modelling technologies by researchers who know how to [&#8230;]]]></description>
		
					<wfw:commentRss>https://rosacea-support.org/finding-new-rosacea-drugs-with-computer-models-in-silico.html/feed</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">14329</post-id>	</item>
		<item>
		<title>DFD-29 set to be approved on Nov 4 2024</title>
		<link>https://rosacea-support.org/dfd-29-set-to-be-approved-on-nov-4-2024.html</link>
					<comments>https://rosacea-support.org/dfd-29-set-to-be-approved-on-nov-4-2024.html#respond</comments>
		
		<dc:creator><![CDATA[David Pascoe]]></dc:creator>
		<pubDate>Tue, 26 Mar 2024 11:55:13 +0000</pubDate>
				<category><![CDATA[Minocycline]]></category>
		<category><![CDATA[New Rosacea Treatments]]></category>
		<category><![CDATA[Red Face of Rosacea]]></category>
		<guid isPermaLink="false">https://rosacea-support.org/?p=14318</guid>

					<description><![CDATA[News today that Journey Medical Corporation is looking forward to having their Oracea competitor, still known as DFD-29, approved by the FDA before the end of the year. Having accepted the New Drug Application, the FDA is now in the final stages of approving this new 40mg minocycline that is showing promise as a treatment [&#8230;]]]></description>
		
					<wfw:commentRss>https://rosacea-support.org/dfd-29-set-to-be-approved-on-nov-4-2024.html/feed</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">14318</post-id>	</item>
	</channel>
</rss>
